Mark Shoemaker
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Pharmacology top 5%
- Flavonoids in Medical Research
Papers in
-
- Natural product bioactivities and synthesis 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Flavonoids in Medical Research 2
- Inflammatory mediators and NSAID effects 2
- Pharmacological Effects of Medicinal Plants 1
- Co-authors
- Isaac Cohen (7 shared papers)Michael J. Campbell (3 shared papers)Michael J. Campbell (1 shared paper)Emma Shtivelman (4 shared papers)Corina Marx (3 shared papers)Mary Tagliaferri (3 shared papers)Christopher C. Benz (2 shared papers)Emanuel F. Petricoin (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Biology & Therapy (1 paper)Phytotherapy Research (1 paper)Breast Cancer Research and Treatment (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Mark Shoemaker
11 papers receiving 883 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 296
- Pharmacology 210
- Complementary and alternative medicine 69
- Pharmacology 73
- Toxicology 27
Countries citing papers authored by Mark Shoemaker
This map shows the geographic impact of Mark Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shoemaker more than expected).
Fields of papers citing papers by Mark Shoemaker
This network shows the impact of papers produced by Mark Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shoemaker. The network helps show where Mark Shoemaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Shoemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 286 | |
| 2 | 2005 | 197 | |
| 3 | 2006 | 84 | |
| 4 | Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. | 1986 | 77 |
| 5 | 2009 | 74 | |
| 6 | 2004 | 72 | |
| 7 | Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. | 2003 | 59 |
| 8 | 2008 | 38 | |
| 9 | 2009 | 29 | |
| 10 | 2004 | 10 | |
| 11 | 2004 | 5 |
About Mark Shoemaker
Mark Shoemaker is a scholar working on Molecular Biology, Pharmacology, Cancer Research, Surgery and Organic Chemistry, having authored 11 papers that have together received 931 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), Lipoproteins and Cardiovascular Health (3 papers), Natural product bioactivities and synthesis (2 papers), Flavonoids in Medical Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Inflammatory mediators and NSAID effects (2 papers), Pharmacological Effects of Medicinal Plants (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Cancer Research (296 citations), Pharmacology (210 citations), Complementary and alternative medicine (69 citations), Pharmacology (73 citations) and Toxicology (27 citations). Mark Shoemaker has collaborated with scholars based in United States and Canada. Frequent co-authors include Isaac Cohen, Michael J. Campbell, Michael J. Campbell, Emma Shtivelman, Corina Marx, Mary Tagliaferri, Christopher C. Benz, Emanuel F. Petricoin, Anjali S. Kumar and Lance A. Liotta. Their work appears in journals such as Journal of Clinical Oncology, Cancer Biology & Therapy, Phytotherapy Research, Breast Cancer Research and Treatment and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.